• 1
    Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930936.
  • 2
    McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008;51:14191428.
  • 3
    Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res 2006;29:8493.
  • 4
    McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin 2005;21:261280.
  • 5
    Toprak O, Cirit M, Bayata S, Yesil M. Review of the radiocontrast nephropathy risk profiles and risk stratifi cation. Anadolu Kardiyol Derg 2004;4:331335.
  • 6
    Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004;44:13931399.
  • 7
    Kohli HS, Bhaskaran MC, Muthukumar T, et al. Treatment-related acute renal failure in the elderly: A hospital-based prospective study. Nephrol Dial Transplant 2000;15:212217.
  • 8
    Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:15421548.
  • 9
    Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:22592264.
  • 10
    Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;951:1319.
  • 11
    Liss P, Carlsson PO, Palm F, Hansell P. Adenosine A1 receptors in contrast-media induced renal dysfunction in the normal rat. Eur Radiol 2004;14:12971302.
  • 12
    Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002;39:11131119.
  • 13
    McCullough PA, Stacul F, Becker CR, et al. Contrast-Induced Nephropathy Consensus Working Panel: Executive summary. Rev Cardiovasc Med 2006;7:177197.
  • 14
    Tumlin J, Stacul F, Adam A, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006;98(6A):14K20K.
  • 15
    Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: State of the art. Nephrol Dial Transplant 2005;20:15421550.
  • 16
    Heyman SN, Rosen S, Brezis M. Radiocontrast nephropathy: A paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 1994;2:153157.
  • 17
    Aspelin P, Aubry P, Fransson SG, et al. Nephortoxic effects in high-risk patients undergoing angeography. N Engl J Med 2003;348:491499.
  • 18
    Ueda J, Nygren A, Hansell P, Ulfendahl HR. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiologica 1993;34:8387.
  • 19
    Battenfeld R, Khater A el-R, Drommer W, Guenzel P, Kaup FJ. Ioxaglate-induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats. Invest Radiol 1991;26:3539.
  • 20
    Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: Hypertonic versus oxidative stress. Invest Radiol 2002;37:428434.
  • 21
    Hardiek K, Katholi RE, Ramkumar V, Deitrick C. Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol 2001;280:6170.
  • 22
    Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:1422.
  • 23
    Lancelot E, Idee JM, Couturier V, Vazin V, Corot C. Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: A potential cause of nephrotoxicity. J Appl Toxicol 1999;19:341346.
  • 24
    Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004;79:211219.
  • 25
    Larson TS, Hudson K, Mertz JI, Romero JC, Knox FG. Renal vasoconstrictive response to contrast media. The role of sodium balance and the renin-angiotensin system. J Lab Clin Med 1983;101:385391.
  • 26
    Heyman SN, Brezis M, Reubinoff CA, Greenfeld Z, Lechene C, Epstein FH, Rosen S. Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988;82:401412.
  • 27
    Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for preventing of contrastinduced nephropathy in diabetic patients: A randomized study. Indian Heart J 1999;51:521526.
  • 28
    Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease. Am J Med 2004;1164:263272.
  • 29
    Gibbons GH. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: The homeostatic balance between angiotensin II and nitric oxide. Clin Cardiol 1997;20(Suppl 2):1825.
  • 30
    Fleming I, Kohlstedt K, Busse R. New fACEs to the renin-angiotensin system. J Appl Physiol 2005;20:9195.
  • 31
    Munzel T, Keaney JF Jr. Are ACE inhibitors a ‘magic bullet’ against oxidative stress?Circulation 2001;104:15711574.
  • 32
    Lee HT, Kim M, Kim J, Kim N, Emala CW. TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis. Am J Nephrol 2007;27:416424.
  • 33
    Junaid A, Rosenberg ME, Hostetter TH. Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney. J Am Soc Nephrol 1997;8:17321738.
  • 34
    Cirit M, Toprak O, Yesil M, Bayata S, Postaci N, Pupim L, Esi E. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract 2006;104:c20–c27.
  • 35
    Mahajan S, Tiwari S, Bhowmik D, Agarwal SK, Tiwari SC, Dash SC. Factors affecting the outcome of acute renal failure among the elderly population in India: A hospital based study. Int Urol Nephrol 2006;38:391396.
  • 36
    Omer Toprak. Letter to the editor: Angiotensin converting enzyme inhibitors and contrast-induced nephropathy. Renal Failure 2006;28:99100.
  • 37
    Krusová D, Sevela K, Králová D, Zák P, Olovská, V.Risky medication and contrast media-induced nephropathy in patients with diabetes and hypertension. Vnitr Lek 2006;52:10141020.
  • 38
    Huber W, Schipek C, Ilgmann K, et al. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. Am J Cardiol 2003;91:1157–1162.
  • 39
    Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 2004;44:17631771.
  • 40
    Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS. Renal considerations in angiotensin converting enzyme inhibitor therapy: A statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 2001;104:19851991.
  • 41
    El-Harakeeh MA, Kleiner M, Ahern K, Saggi S. Effects of chronic angiotensin receptor blockers and ACE inhibitors use on the incidence of contrast induces nephropathy in patients with chronic renal insufficiency. J Am Soc Nephrol 2004;15:347A, SA-PO214.
  • 42
    Caldicott WJ, Hollenberg NK, Abrams HL. Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol 1970;5:539547.
  • 43
    Brezis M, Greenfeld Z, Shina A, Rosen S. Angiotensin II augments medullary hypoxia and predisposes to acute renal failure. Eur J Clin Invest 1990;20:199207.